ロード中...
Insulin doses requirements in patients with type 1 diabetes using glargine U300 or degludec in routine clinical practice
There are not many real-world studies evaluating daily insulin doses requirements (DIDR) in patients with type 1 diabetes (T1D) using second-generation basal insulin analogs, and such comparison is necessary. The aim of this study was to compare DIDR in individuals with T1D using glargine 300 UI/mL...
保存先:
| 出版年: | J Investig Med |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8223633/ https://ncbi.nlm.nih.gov/pubmed/33771843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jim-2020-001633 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|